Molecular genetic analysis of drug addiction
Molecular genetic analysis of drug addiction
批准号:
7566020
负责人:
Julie A Blendy
金额:
$35.45万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-01 至 2011-01-31
关键词:
AcuteAddictive BehaviorAddressAmygdaloid structureAnimal ModelAnimalsAntibodiesAreaBehaviorBehavioralBrainBrain regionBrain-Derived Neurotrophic FactorCREB1 geneCell NucleusCellsClinicCocaineCorticosteroneCorticotropin-Releasing Hormone ReceptorsCuesCyclic AMP-Responsive DNA-Binding ProteinDevelopmentDrug AddictionDrug usageDynorphinsExperimental DesignsExposure toExtinction (Psychology)Gene ExpressionGene TargetingGenesHumanImmediate-Early GenesImmunohistochemistryInvestigationKnock-outLabelLaboratoriesLinkLocationMediatingModelingMolecularMolecular GeneticsMorphineMusMutant Strains MiceMutationNeuronsNicotinePathway interactionsPatternPharmaceutical PreparationsPropertyProtein IsoformsProteinsReceptor ActivationRecording of previous eventsRegulationRelapseResearchResearch PersonnelRewardsRoleSamplingScreening procedureSelf AdministrationShockSignaling MoleculeSiteStagingStressSwimmingTestingTherapeuticTranslatingWild Type Mouseactivating transcription factoraddictionchromatin immunoprecipitationconditioningdisorder later incidence preventiondrug cravingdrug of abusedrug relapsedrug rewardfootgenetic analysisneural circuitneurochemistrynovelpreferenceprogramspromoterprotein activationresponsestressortranscription factor
中文摘要
成功治疗毒瘾的一个关键障碍是复吸,复吸往往是由吸毒成瘾者的行为所引起的。
暴露在压力之下在动物研究中,通过恢复对药物的反应,
自我管理或条件性位置偏爱(CPP)的药物,线索或压力。我们和其他人,
研究表明,各种滥用药物,如吗啡、可卡因和最近的尼古丁,
激活转录因子CREB(cAMP反应元件结合蛋白),这种激活是
对这些药物的后续行为反应所必需的。最近,我们已经证明CREB是
可卡因条件性位置偏爱(CPP)的应激诱导恢复所需的,但不是药物-
诱导恢复。小鼠是一种易于处理的动物模型,其允许研究在治疗期间的复发。
行为水平、神经回路和分子机制。在这个提案中,我们将利用老鼠
CREB中靶向突变的纯合子(CREB 1 ^突变小鼠),以检验CREB是一个突变体的假设。
压力诱导的药物寻求行为的恢复所需的中央信号分子。我们
将在三个具体目标中检验这一核心假设。在目标1中,我们将研究是否激活
转录因子CREB对于各种疾病后的恢复行为的表现至关重要,
应激源使用条件性位置偏好范式(CPP),并确定皮质酮的作用
和本回复中的CRF。由于压力和可卡因都能恢复野生型小鼠的CPP,这些回路必须
汇聚在一条最终的共同道路上在目标2中,我们将确定压力与药物的特定途径
诱导恢复,以及收敛点。此外,逆行追踪研究将使我们能够
以确定这些神经元在恢复电路中关键大脑区域的精确位置。最后,在
目的3:我们将确定哪些基因在这些关键脑区是直接CREB靶基因。这些研究
将使我们能够解决药物复发的分子机制。此信息将
对于开发专注于CREB及其调节的药理学方法很有价值。
靶基因这些研究可能会产生新的潜在治疗方法,最终可以转化为
预防人类复发的诊所
英文摘要
A key obstacle to successful treatment of drug addiction is relapse, which is frequently precipitated by
exposure to stress. Relapse has been modeled in animal studies through reinstatement of responses to drug
self-administration or conditioned place preference (CPP) by drug, cue or stress. We and others, have
demonstrated that a variety of drugs of abuse, such as morphine, cocaine and more recently nicotine, can
activate the transcription factor CREB (cAMP response element binding protein) and this activation is
necessary for subsequent behavioral responses to these drugs. More recently, we have shown that CREB is
required for stress-induced reinstatement of cocaine conditioned place preference (CPP), but not drug-
induced reinstatement. The mouse is a tractable animal model that allows for investigation of relapse at the
levels of behavior, neural circuitry and molecular mechanisms. In this proposal we will utilize mice
homozygous for a targeted mutation in CREB (CREB1^ mutant mice) to test the hypothesis that CREB is a
central signaling molecule required for stress inducedreinstatement of drug seeking behavior.We
will test this central hypothesis in three specific aims. In Aim 1, we will investigate if activation of the
transcription factor CREB is critical for the manifestation of reinstatement behavior following various
stressors using a conditioned place preference paradigm (CPP), and determine the role of corticosterone
and CRF in this response. As both stress and cocaine reinstate CPP in wild type mice, these circuits must
converge on a final common pathway. In Aim 2, we will identify the pathways specific for stress versus drug
induced reinstatement, as well as points of convergence. Moreover, retrograde tracing studies will enable us
to identify the precise location of these neurons in key brain areas in the reinstatement circuitry. Lastly, in
Aim 3 we will determine which genes in these key brain areas are direct CREB target genes. These studies
will allow us to address the molecular mechanisms underlying drug relapse. This information will be
valuable for the development of pharmacotherapeutic approaches that focus on regulation of CREB and its
target genes. These studies may give rise to novel potential therapeutics that can ultimately be translated to
the clinic for relapse prevention in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Low-input profiling of brain-region and cell-type specific epigenomic dynamics to understand gene-environment interactions in opioid addiction
-
批准号:10605801
-
项目类别:
-
资助金额:$73.23万
-
财政年份:2023
-
负责人:Julie A Blendy
-
依托单位:
Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologies
-
批准号:10293782
-
项目类别:
-
资助金额:$51.63万
-
财政年份:2021
-
负责人:Julie A Blendy
-
依托单位:
Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologies
-
批准号:10493185
-
项目类别:
-
资助金额:$48.25万
-
财政年份:2021
-
负责人:Julie A Blendy
-
依托单位:
Mapping opioid-dependence state transitions across structural, functional, and transcriptomic topologies
-
批准号:10622531
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2021
-
负责人:Julie A Blendy
-
依托单位:
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
-
批准号:10347354
-
项目类别:
-
资助金额:$69.65万
-
财政年份:2020
-
负责人:Julie A Blendy
-
依托单位:
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
-
批准号:10552037
-
项目类别:
-
资助金额:$69.65万
-
财政年份:2020
-
负责人:Julie A Blendy
-
依托单位:
Neonatal Opioid Exposure and Withdrawal: Molecular and Behavioral Consequences
-
批准号:9911467
-
项目类别:
-
资助金额:$71.08万
-
财政年份:2020
-
负责人:Julie A Blendy
-
依托单位:
AMP-activated protein kinase (AMPK) and nicotine dependence
-
批准号:9441755
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2016
-
负责人:Julie A Blendy
-
依托单位:
T32 Translational Addiction Research Fellowship Program
-
批准号:10159223
-
项目类别:
-
资助金额:$48.79万
-
财政年份:2010
-
负责人:Julie A Blendy
-
依托单位:
T32 Translational Addiction Research Fellowship Program
-
批准号:10628649
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2010
-
负责人:Julie A Blendy
-
依托单位:
T32 Translational Addiction Research Fellowship Program
-
批准号:10400087
-
项目类别:
-
资助金额:$51.64万
-
财政年份:2010
-
负责人:Julie A Blendy
-
依托单位:
Administrative Core
-
批准号:7612869
-
项目类别:
-
资助金额:$25.04万
-
财政年份:2009
-
负责人:Julie A Blendy
-
依托单位:
Molecular and Behavioral Effects of Nicotine Deprivation
-
批准号:7612864
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2009
-
负责人:Julie A Blendy
-
依托单位:
Functional Characterization of OPRM1 A118G in Nicotine Dependence
-
批准号:8133270
-
项目类别:
-
资助金额:$6.52万
-
财政年份:2009
-
负责人:Julie A Blendy
-
依托单位:
Functional Characterization of OPRM1 A118G in Nicotine Dependence
-
批准号:7713676
-
项目类别:
-
资助金额:$49.46万
-
财政年份:2009
-
负责人:Julie A Blendy
-
依托单位:
The Role of CREB and Opioid System in Nicotine Reward
-
批准号:6864073
-
项目类别:
-
资助金额:$12.05万
-
财政年份:2004
-
负责人:Julie A Blendy
-
依托单位:
GENETIC ANALYSIS OF DRUG ADDICTION
-
批准号:6624759
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2000
-
负责人:Julie A Blendy
-
依托单位:
GENETIC ANALYSIS OF DRUG ADDICTION
-
批准号:6329161
-
项目类别:
-
资助金额:$27.25万
-
财政年份:2000
-
负责人:Julie A Blendy
-
依托单位:
GENETIC ANALYSIS OF DRUG ADDICTION
-
批准号:6042611
-
项目类别:
-
资助金额:$27.6万
-
财政年份:2000
-
负责人:Julie A Blendy
-
依托单位:
GENETIC ANALYSIS OF DRUG ADDICTION
-
批准号:6475989
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2000
-
负责人:Julie A Blendy
-
依托单位:
海外基金